Can excess adipose tissue and hyperinsulinemia promote inflammation, raise hs-CRP, and stress the liver?

Excess adiposity—especially visceral/abdominal fat—has the clearest evidence as an upstream driver of a linked inflammatory, insulin-resistant, and liver-fat accumulation phenotype. Hyperinsulinemia is part of this network and may also contribute directly to hepatic lipid stress, although it often reflects the same underlying insulin-resistant state.

Inflammation and hs-CRP

• Visceral adipose expansion promotes adipocyte lipid stress, macrophage accumulation, and release of TNF-α, IL-6, IL-1β, MCP-1, and related mediators. Sustained weight loss reducing circulating IL-6 supports adiposity as a modifiable determinant of this inflammatory activity.
• hs-CRP is produced predominantly by the liver. Visceral fat-associated IL-6, delivered through the portal circulation, can stimulate hepatocyte CRP synthesis, providing a coherent pathway from abdominal adiposity to higher hs-CRP.
• Higher fasting insulin is associated with inflammatory markers and hs-CRP. In a Japanese adult cohort, fasting insulin showed a dose-dependent adjusted association with hs-CRP (β=0.130, SE 0.016; P<0.001), but this should be interpreted within the broader adiposity–insulin-resistance–inflammation cluster.

Mechanistic metabolic feedback

• Cytokines can impair insulin signaling through inhibitory IRS phosphorylation and IL-6/SOCS3 signaling. The resulting insulin resistance increases compensatory pancreatic insulin secretion, producing hyperinsulinemia.
• Hyperinsulinemia may then sustain hepatic de novo lipogenesis through SREBP-1c and ChREBP, while adipose insulin resistance increases fatty-acid delivery to the liver.

Liver implications

• These convergent pathways promote hepatic triglyceride accumulation (steatosis), followed by lipotoxicity, mitochondrial oxidative stress, endoplasmic-reticulum stress, inflammation, and hepatocyte injury.
• ALT alone does not assess fibrosis risk; in abdominal obesity with another cardiometabolic risk factor, guideline-directed assessment includes metabolic testing and FIB-4, with elastography when indicated.

Bottom line

• Excess visceral adiposity can promote cytokine signaling, higher hs-CRP, and metabolic liver stress. Hyperinsulinemia plausibly reinforces these processes, with the strongest mechanistic evidence for hepatic fat accumulation rather than fibrosis.